Marino F, Marcoli M, De Ponti F, Cosentino M, Lecchini S, Frigo G M
Department of Internal Medicine and Therapeutics, II Faculty of Medicine, University of Pavia, Italy.
Naunyn Schmiedebergs Arch Pharmacol. 1994 Nov;350(5):499-506. doi: 10.1007/BF00173019.
In order to clarify whether adrenoceptors in the guinea-pig distal colon are under sympathetic control, we assessed possible variations in the sensitivity to adrenoceptor agonists after blockade of neuronal catecholamine uptake mechanisms by desipramine (DMI). First, experiments were carried out to investigate the effects of DMI added in the organ bath on propulsion velocity, endogenous and [3H] prelabelled acetylcholine overflow, electrically evoked noradrenaline overflow and longitudinal smooth muscle tone. Secondly, we studied the effects of adrenoceptor agonists on the above parameters in untreated animals and in animals chronically treated with DMI. DMI added in the organ bath at concentrations equal to or higher than 30 nM inhibited all the parameters under study. Thus, when evaluating the effect of DMI on concentration-response curves to adrenoceptor agonists, concentrations which were per se inactive were used. DMI added in the organ bath at concentrations up to 30 nM potentiated the inhibitory effects of exogenous noradrenaline on propulsion velocity and acetylcholine overflow, but it did not affect the concentration-response curve to exogenous noradrenaline on longitudinal smooth muscle tone. Furthermore, 30 nM DMI inhibited propulsion velocity during sympathetic nerve stimulation. In preparations obtained from animals chronically treated with DMI, no significant change of propulsion velocity, endogenous and [3H] prelabelled acetylcholine overflow was found with respect to untreated animals. Nevertheless, in such preparations subsensitivity to isoprenaline (acting mainly on muscular beta-adrenoceptors) and clonidine (acting on neuronal alpha 2-adrenoceptors) and super-sensitivity to phenylephrine were observed. Electrically evoked noradrenaline overflow was enhanced, in a frequency-dependent way, by yohimbine and inhibited by clonidine.(ABSTRACT TRUNCATED AT 250 WORDS)
为了阐明豚鼠远端结肠中的肾上腺素能受体是否受交感神经控制,我们评估了用去甲丙咪嗪(DMI)阻断神经元儿茶酚胺摄取机制后,对肾上腺素能受体激动剂敏感性的可能变化。首先,进行实验以研究加入器官浴中的DMI对推进速度、内源性和[3H]预标记乙酰胆碱溢出、电诱发去甲肾上腺素溢出以及纵行平滑肌张力的影响。其次,我们研究了肾上腺素能受体激动剂对未处理动物和长期用DMI处理的动物上述参数的影响。加入器官浴中的浓度等于或高于30 nM的DMI抑制了所有研究的参数。因此,在评估DMI对肾上腺素能受体激动剂浓度-反应曲线的影响时,使用本身无活性的浓度。加入器官浴中的浓度高达30 nM的DMI增强了外源性去甲肾上腺素对推进速度和乙酰胆碱溢出的抑制作用,但不影响外源性去甲肾上腺素对纵行平滑肌张力的浓度-反应曲线。此外,30 nM DMI在交感神经刺激期间抑制推进速度。在从长期用DMI处理的动物获得的标本中,与未处理动物相比,未发现推进速度、内源性和[3H]预标记乙酰胆碱溢出有显著变化。然而,在这类标本中,观察到对异丙肾上腺素(主要作用于肌肉β-肾上腺素能受体)和可乐定(作用于神经元α2-肾上腺素能受体)的敏感性降低,而对去氧肾上腺素的敏感性增加。电诱发的去甲肾上腺素溢出以频率依赖的方式被育亨宾增强,并被可乐定抑制。(摘要截短于250字)